Inderes osakeanalyysipalvelu

Inderes.com - Award Winning Research

How to Invest in Stocks?

Grown out of passion for stock investing, our dedicated analyst team finds you the best equity picks in Finland. Checkout the 5 steps to become a stock investor!

Hae meille töihin! Etsimme mm. streaming-asiantuntijoita ja sisällöntuottajia.

Katso →

Recent updates

Stock releases

Forum

Stock exchange releases

19.4.

19.4. [Management transactions]

Transactions under Novozymes’ stock buyback program

19.4. [Stock exchange releases]

Bravida Holding AB: Invitation to presentation of Bravida's report for the first quarter 2021

19.4. [Stock exchange releases]

Cyviz AS: New share capital registered

19.4. [Stock exchange releases]

Momentum Group AB (publ): Invitation to a presentation of the Momentum Group's Interim Report for the first quarter 2021

19.4. [Stock exchange releases]

Press and analyst meeting

19.4. [Stock exchange releases]

Biogen Advances Leading Research in Spinal Muscular Atrophy (SMA) with New Data at AAN 2021 Exploring Opportunities to Improve Outcomes for Patients

19.4. [Stock exchange releases]

Arcus ASA: Altia has received conditional approval for the merger from the Finnish Competition and Consumer Authority

19.4. [Stock exchange releases]

Altia has received conditional approval for the merger from the Finnish Competition and Consumer Authority

19.4. [Stock exchange releases]

SFL - Notice of Annual General Meeting 2021

19.4. [Stock exchange releases]

Proventus Capital Partners IV B: PROVENTUS CAPITAL PARTNERS IV B ISSUES NEW DEBENTURES

19.4. [Stock exchange releases]

Bombardier Announces Expiration of its Cash Tender Offer for Certain Outstanding Senior Notes

19.4. [Stock exchange releases]

Signify share repurchase periodic update

19.4. [Stock exchange releases]

Proventus Capital Partners IV: PROVENTUS CAPITAL PARTNERS IV ISSUES NEW DEBENTURES

19.4. [Stock exchange releases]

Medivir has determined the starting dose for the next part of the phase Ib study with MIV-818

19.4. [Stock exchange releases]

Nordnet's profit for the first quarter 2021 substantially exceeds market expectations

19.4. [Stock exchange releases]

Opening of new fixed-rate bond

19.4. [Stock exchange releases]

Equinor ASA: Notice of annual general meeting on 11 May 2021

19.4. [Stock exchange releases]

Nitro Games Oyj: Webcast with Teleconference, Q1 / 2021

19.4. [Stock exchange releases]

Nobia AB: Invitation to presentation of Q1 interim report 2021

19.4. [Stock exchange releases]

Company announcement 6/2021

Forum

Visit the forum

Uusimmat julkaisut

Verkkokauppa.com reports its Q1 result on this week’s Friday, 23rd of April. We have made small estimate adjustments and expect Q1 sales to grow by 7.5% y/y to EUR 135m. We expect adj. EBIT of EUR 5m. We retain our rating “BUY” with TP of EUR 10.5 (9.5).

The Q1 report confirmed that Evli is in excellent form and the company’s growth outlook for the next few years remain good as risks are limited to the current market situation.

Redeye endorses the new study supporting TK1 as a predictive biomarker for prostate cancer. We are encouraged in the strengthening of data for this specific indication and expect AroCell to accelerate further with this cancer type once it has progressed with its focus on breast cancer.

Netcompany has had a solid start to 2021, with no real negative impact from Covid-19.

Redeye views the news that LifeClean Disinfection has received a CE mark based on EU medical technology directives (MDD) as very positive. We expected this to pass, but the actual approval is a positive sign for the sales potential in healthcare in Europe.

Starbreeze announced earlier this morning that it had signed a licensing agreement with PopReach for the re-launch of the mobile game PAYDAY Crime War. In conjunction with this important news we hereby also announce the re-launch of Redeye’s coverage of Starbreeze.

Redeye maintains its base case of SEK 205 per share, at this time. Medicover delivered impressive results for Q1: revenues, EBITDA and EBIT were above our expectations. We are bracing ourselves for an even better Q2.

You are not logged in.

"Get access to reommendations, target prices & our morning update by creating an Inderes Free account"

Go Inderes Free

New company reports

16.4. Evli Pankki

Evli Bank: The going gets good

Lisää
12.4. Sanoma

Sanoma: Learning is now in the driver's seat

Vähennä
8.4. Remedy

Remedy: Several playable levels in the growth game

Lisää
6.4. Relais Group

Relais: Another interesting acquisition

Vähennä
30.3. Tecnotree

Tecnotree: A well-performing phoenix

Osta
8.3. Nightingale

Nightingale Health: A promise in preventive health care with high risk
4.3. Remedy

Remedy: We keep our eye on the long game

Lisää
3.3. Exel Composites

Exel Composites: Super clinical finish

Lisää
24.2. CapMan

CapMan: Time to deliver on promises

Lisää
11.2. Sanoma

Sanoma: Valuation has jumped the gun

Vähennä
8.2. Solteq

Solteq: On its way from a retail sector IT consultant to a product house

Lisää
5.2. CapMan

This year it is all-in

Lisää
15.1. Siili Solutions

Growth at a reasonable price

Lisää
22.12. Efecte

Cashing of growth ticket proceeding

Lisää
10.12. Harvia

Hop on the consolidation train of the sauna market

Osta
14.10. Rapala VMC

Patience may yet be rewarded with a great catch

Lisää
5.10. F-Secure

Wait for the acceleration of growth continues

Vähennä
14.9. Qt

Qt Group: Perfection in performance and valuation

Lisää
21.7. LeadDesk

Towards scalable growth

Lisää
24.4. Suominen

The report was promising sign regarding longer term

Lisää

Forum

Visit the forum

Hei!

Inderes.com - Award Winning Research

How to Invest in Stocks?

Hae meille töihin! Etsimme mm. streaming-asiantuntijoita ja sisällöntuottajia.

OMX Helsinki 25

OMX Helsinki Cap_PI

OMX Helsinki_PI

Recent updates

Stock releases

Forum

Stock exchange releases

19.4.

Forum

Uusimmat julkaisut

Verkkokauppa: Expecting good Q1 figures - Evli

Arocell: Resumed FDA review - Redeye

Evli Bank: The going gets good

Arocell: Strengthened clinical data on prostate cancer - Redeye

Seamless Distribution Systems: Preliminary Q1 2021 figures - Redeye

Netcompany: Off to a good start - Nordea

Lifeclean: CE mark – Done - Redeye

Flexion Mobile: Ramping-up the portfolio - Redeye

Starbreeze: Re-launch of coverage - Redeye

Medicover: Q1: Spectacular results - Redeye